Details for New Drug Application (NDA): 005490
✉ Email this page to a colleague
NDA 005490 describes LYNORAL, which is a drug marketed by Organon Usa Inc and is included in one NDA. Additional details are available on the LYNORAL profile page.
The generic ingredient in LYNORAL is ethinyl estradiol. There is one drug master file entry for this compound. Additional details are available on the ethinyl estradiol profile page.
The generic ingredient in LYNORAL is ethinyl estradiol. There is one drug master file entry for this compound. Additional details are available on the ethinyl estradiol profile page.
Summary for 005490
| Tradename: | LYNORAL |
| Applicant: | Organon Usa Inc |
| Ingredient: | ethinyl estradiol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 005490
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.05MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.01MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
